Vol. 41 | No. 1 | January-June 2013Back

Open Access

Aldosterone Antagonists in the Prevention of Atrial Fibrillation in Adult Patients with Congestive Heart Failure: A Meta-analysis of Randomized Controlled Trials

Joanne A. Cosare, Evelyn A. Esposo
Jun 2013 DOI 10.69944/pjc.14345d418b

More Info

Joanne A. Cosare, MD, Evelyn A. Esposo, MD 

St. Luke’s Medical Center, Quezon City, Philippines

References
  1. O’Meara E, Khairy P, Blanchet MC, et al. Mineralcorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction. Insight from the Atrial Fibrillation and Congestive Heart Failure Trial. Circ Heart Fail 2012;5:586-593. 
  2. Libby P, Braunwald E. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia: Saunders/Elsevier, 2008. 
  3. Mann DL, Bristow MR. Mechanisms and model in heart failure: the biochemical model and beyond. Circulation 2005;111:2837-2849.
  4. Struthers AD. Aldosterone: cardiovascular assault. Am Heart J 2002;144(suppl.5):S2-S7. 
  5. Dabrowski R, Szwed H. Antiarrhythmic potential of aldosterone antagonists in atrial fibrillation. Cardiology Journal 2012;19:223- 229. 
  6. Pei DA, Li L, Xu Zy, et al. Expression of mineralcorticoid receptor and 11-betahydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases. Zhonghua Yi Xue Za Zhi. 2007;87:816-819. 
  7. Gao X, Peng L, Adhikari CM, et al. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail 2007;13:170-177. 
  8. Swedberg K, Zannad F, McMurray J, et al. Eplerenone and Atrial Fibrillation in mild systolic heart failure. Results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure) Study. JACC 2012.59;1598-1603. 
  9. Boccanelli A, Mureddu GF, Cacciatore G, et al. Anti-remodeling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results. European Journal of Heart Failure 2009;11:68-76. 
  10. Zannad F, McMurray J, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms (results from EMPHASIS HF). N Engl J Med 2011;364:11-21. 
  11. Maron B, Leopold J, et al. Aldosterone Receptor Antagonists: Effective but Often Forgotten. Circulation 2010;121:934-939.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.